A Koch, H Cox, V Mizrahi - Current Opinion in pharmacology, 2018 - Elsevier
Highlights•Management of tuberculosis is complicated by high levels of drug resistance in some regions of the world.•Increasingly, molecular diagnostics are being used for resistance …
Strain-specific genomic diversity in the Mycobacterium tuberculosis complex (MTBC) is an important factor in pathogenesis that may affect virulence, transmissibility, host response …
F Coll, R McNerney, MD Preston… - Genome medicine, 2015 - Springer
Mycobacterium tuberculosis drug resistance (DR) challenges effective tuberculosis disease control. Current molecular tests examine limited numbers of mutations, and although whole …
D Couvin, A David, T Zozio, N Rastogi - Infection, Genetics and Evolution, 2019 - Elsevier
In order to provide a global overview of genotypic, epidemiologic, demographic, phylogeographical, and drug resistance characteristics related to the prevailing tuberculosis …
Tuberculosis (TB) was once a major killer in Europe, but it is unclear how the strains and patterns of infection at 'peak TB'relate to what we see today. Here we describe 14 genome …
D Heemskerk, M Caws, B Marais, J Farrar - 2015 - Springer
This monograph is written for healthcare workers in any setting who are faced with the complex care for patients with tuberculosis. Prevention, diagnosis and treatment of …
Due to its rapid spread and association with the numerous outbreaks, the global spread of East Asian lineage of Mycobacterium tuberculosis strains presents a global concern …
Tuberculosis remains a major global health problem. Laboratory diagnostic methods that allow effective, early detection of cases are central to management of tuberculosis in the …
M Ezewudo, A Borens, Á Chiner-Oms, P Miotto… - Scientific reports, 2018 - nature.com
Drug-resistant tuberculosis poses a persistent public health threat. The ReSeqTB platform is a collaborative, curated knowledgebase, designed to standardize and aggregate global …